APA (7th ed.) Citation

Liu, R., Li, Z., Chen, R., Fang, Z., Liu, Z., & Liu, H. EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction. Nature Portfolio.

Chicago Style (17th ed.) Citation

Liu, Rui, Zongwei Li, Rui Chen, Zhihong Fang, Zhiqiang Liu, and Huan Liu. EZH2 Serves as a Viable Therapeutic Target for Myeloma-induced Osteolytic Bone Destruction. Nature Portfolio.

MLA (9th ed.) Citation

Liu, Rui, et al. EZH2 Serves as a Viable Therapeutic Target for Myeloma-induced Osteolytic Bone Destruction. Nature Portfolio.